Spiriva

Researchers tested three inhaled treatments: doubling the steroid dose, adding Glaxo's Serevent or adding Boehringer Ingelheim's Spiriva, which is approved for emphysema and other chronic lung conditions, but not asthma.

New Treatment For Adults With Hard-To-Control Asthma 2010

Researchers tested three inhaled treatments: doubling the steroid dose, adding Glaxo's Serevent or adding Boehringer Ingelheim's Spiriva, which is approved for emphysema and other chronic lung conditions, but not asthma.

New Treatment For Adults With Hard-To-Control Asthma 2010

Kesten said researchers who had raised concerns about the currently marketed version of Spiriva, known as Spiriva HandiHaler, did not have access to all the most recent data and the level of detail available to the company.

unknown title 2009

Journal of the American Medical Association that inhaled anticholinergics such as Spiriva and Boehringer's older drug Atrovent (ipratropium) are associated with significantly increased risk of cardiovascular death, myocardial infarction or stroke.

PharmaTimes World News 2009

AstraZeneca PLC's Symbicort and Boeringer Ingelheim GmbH's Spiriva will start losing patent protection in some countries.

Novartis's Sandoz Buys Oriel Therapeutics 2010

Spiriva is a promising alternative asthma treatment and some doctors are already using it in people who don't respond to steroid medicine, but more study on drug safety is needed, Dr. Lewis Smith of Northwestern University wrote in an accompanying editorial.

New Treatment For Adults With Hard-To-Control Asthma 2010

GlaxoSmithKline PLC's Advair — which originally wasn't developed for COPD — and Boehringer Ingelheim GmbH and Pfizer Inc. 's Spiriva jointly garner annual revenue of more than $5 billion.

Eating Into Apple's Cash Pile 2010

"In the end, the study results provided the truth" – the drug, Spiriva, was as good as Glaxo's Serevent, they wrote.

New Treatment For Adults With Hard-To-Control Asthma 2010

GlaxoSmithKline PLC's Advair — which originally wasn't developed for COPD — and Boehringer Ingelheim GmbH and Pfizer Inc. 's Spiriva jointly garner annual revenue of more than $5 billion.

Eating Into Apple's Cash Pile 2010

GlaxoSmithKline PLC's Advair — which originally wasn't developed for COPD — and Boehringer Ingelheim GmbH and Pfizer Inc. 's Spiriva jointly garner annual revenue of more than $5 billion.

Eating Into Apple's Cash Pile 2010